IV therapy has been used for decades in hospitals to treat a range of conditions, from dehydration to nutrient-absorption disorders, but it's increasingly offered at independent clinics and ...

Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...

Dr. Howard Schumaker and Tina Schumaker to open Relevate Ketafusion clinic in La Crosse, offering IV ketamine therapy for ...

Intravenous antihypertensive agents for the ... The rapid recognition and initiation of therapy are key to minimizing end-organ damage in patients with hypertensive emergency.

EDWARDSVILLE - There’s a new spot in Edwardsville for all your health and wellness needs.NFuze Wellness specializes in IV ...

Johnson & Johnson (NYSE: JNJ) has announced positive results from the Phase 3 ASTRO study evaluating TREMFYA® (guselkumab) ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

Tremfya could become the first IL-23 inhibitor with fully subcutaneous induction and maintenance options in the treatment of ...